Do Pharmaceutical Mergers Harm Drug Innovation?

Business & Finance
Cover of the book Do Pharmaceutical Mergers Harm Drug Innovation? by Jan Schmidt, GRIN Verlag
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Jan Schmidt ISBN: 9783656962168
Publisher: GRIN Verlag Publication: May 15, 2015
Imprint: GRIN Verlag Language: English
Author: Jan Schmidt
ISBN: 9783656962168
Publisher: GRIN Verlag
Publication: May 15, 2015
Imprint: GRIN Verlag
Language: English

Master's Thesis from the year 2013 in the subject Business economics - Miscellaneous, grade: 8,5 (NL, äquivalent zu 1,2), Utrecht University (Law, Economics and Governance), course: Mergers & Akquisitions, language: English, abstract: The number and volume of pharmaceutical companies' mergers and acquisitions have reached exorbitant magnitudes in the last decade, with estimations of over 1,300 deals worth US$ 690 billion between 2000 and 2009.1 The biggest transaction, valued at US$ 66.7 billion2, occurred in 2009 when Pfizer bought Wyeth. The sheer dimension of transactions in this sector, being subject to significant public interest, poses questions about the motivations behind these deals, which are mostly believed to be countermeasures for patent expirations, as well as the impact on drug innovation. Even though, the regular object of interest regarding mergers is the shareholder value, in this specific case drug innovation is of particular interest as it does not only influence the future prospects of the pharmaceutical companies but also long term public health. Hence, the objective of this thesis is to discover what the impact of pharmaceutical mergers on R&D intensity and efficiency of the acquiring organization and on the pharmaceutical industry as a whole is.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Master's Thesis from the year 2013 in the subject Business economics - Miscellaneous, grade: 8,5 (NL, äquivalent zu 1,2), Utrecht University (Law, Economics and Governance), course: Mergers & Akquisitions, language: English, abstract: The number and volume of pharmaceutical companies' mergers and acquisitions have reached exorbitant magnitudes in the last decade, with estimations of over 1,300 deals worth US$ 690 billion between 2000 and 2009.1 The biggest transaction, valued at US$ 66.7 billion2, occurred in 2009 when Pfizer bought Wyeth. The sheer dimension of transactions in this sector, being subject to significant public interest, poses questions about the motivations behind these deals, which are mostly believed to be countermeasures for patent expirations, as well as the impact on drug innovation. Even though, the regular object of interest regarding mergers is the shareholder value, in this specific case drug innovation is of particular interest as it does not only influence the future prospects of the pharmaceutical companies but also long term public health. Hence, the objective of this thesis is to discover what the impact of pharmaceutical mergers on R&D intensity and efficiency of the acquiring organization and on the pharmaceutical industry as a whole is.

More books from GRIN Verlag

Cover of the book Erweiterung einer flexiblen Objektstruktur für die Kommunikation mit Datenservern um Möglichkeiten zur Fernalarmierung by Jan Schmidt
Cover of the book Reformen der Vereinten Nationen im Menschenrechtsschutz in Folge des Reformgipfels 2005. Lösung des 'Demokratiedefizits'? by Jan Schmidt
Cover of the book Das Erleben von Alzheimer by Jan Schmidt
Cover of the book Zum Begriff 'Sozialisation' by Jan Schmidt
Cover of the book Der Formwechsel in Bezug auf BGH by Jan Schmidt
Cover of the book Der Zettelkasten von Niklas Luhmann, das Beschlagworten und die persönliche Materialdokumentation by Jan Schmidt
Cover of the book Focusing - Konzept und Bedeutung by Jan Schmidt
Cover of the book Teilzeitarbeit bei Führungskräften: Eine Untersuchung im öffentlichen Dienst NRW by Jan Schmidt
Cover of the book Sparkle of Existential Time as a Sanctuary in Marital Counselling by Jan Schmidt
Cover of the book Ein Kommentar zum Buch 'La Colmena' von Camilo José Cela by Jan Schmidt
Cover of the book Die Rolle des Staates in den Theorien von John Maynard Keynes und Milton Friedman by Jan Schmidt
Cover of the book Die Energiesicherheit der EU. Umsetzung eines politikwissenschaftlichen Konzepts anhand der bilateralen Beziehung mit Russland by Jan Schmidt
Cover of the book Musterschema zur Nacherfüllung, § 439 BGB by Jan Schmidt
Cover of the book Advertising to Children by Jan Schmidt
Cover of the book Fördermöglichkeiten für Menschen mit einer geistigen Behinderung im Rahmen der Judokurse des HPCA München by Jan Schmidt
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy